A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Effect of Vitamin D Diffiency on Oral Mucosa in Patients Recieving Methotrexate Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
- Status
- TERMINATED
- Phase
- PHASE3
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- N/A
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
- Status
- TERMINATED
- Phase
- PHASE1
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Effects of Exercises on Total Body Health in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
- Status
- COMPLETED
- Phase
- N/A
Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1